The retinoic acid receptor (RAR) ␣, ␤ 2 , and ␥ isotypes each regulate specific subsets of target genes in F9 teratocarcinoma stem cells. We used chromatin immunoprecipitation assays to monitor the association of RAR␥, retinoic X receptor (RXR) ␣, and coregulators with the RAR␤ 2 , Hoxa1, and Cyp26A1 retinoic acid response elements (RAREs) in F9 wild type and RAR␣, -␤ 2 , and -␥ null cells. Additionally we quantitatively monitored expression of the corresponding mRNAs. We demonstrated that the association of RAR␥ and/or RXR␣ with a RARE was not sufficient for retinoic acid (RA)-mediated transcription of the corresponding target gene. However, the ability of RAR␥ and/or RXR␣ to recruit pCIP (AIB1/ACTR/RAC-3/TRAM-1/SRC-3) and p300 to a RARE did correlate with RA-associated transcription of target mRNAs. Therefore, the specific functions of the RAR isotypes do not manifest at the level of their DNA binding but rather from a differential ability to recruit specific components of the transcriptional machinery. We also demonstrated that RA-mediated displacement of the polycomb group protein SUZ12 from a RARE was inhibited in the absence of RAR␥. Thus, transcriptional components of the RAR signaling pathway are specifically required for displacement of SUZ12 from RAREs during RA-mediated differentiation of F9 cells.
Retinoic acid (RA) 2 is an important regulator of vertebrate development and homeostasis because of its role in essential processes such as apoptosis, cell differentiation, and proliferation (1, 2) . The effects of RA are mediated through binding to the retinoic acid receptors (RARs) (3) and retinoic X receptors (RXRs) (4) , which are members of the nuclear receptor superfamily (5) . The RARs and RXRs each have three isotypes (␣, ␤, and ␥), which are encoded by distinct genes. In addition, for each RAR isotype, there are several isoforms generated by differential promoter usage and splicing (3, 4) . The multiple RAR and RXR isotypes and isoforms are conserved in vertebrate evolution and display distinct spatiotemporal expression patterns in developing embryos and adult tissues, suggesting that each receptor performs some unique functions (1) .
RXR-RAR heterodimers bind much more efficiently to retinoic acid response elements (RAREs) than their respective homodimers in vitro (6) , and several lines of evidence support the idea that these heterodimers represent the functional units transducing the retinoid signal in vivo (3) . RAR-RXR heterodimers are thought to be constitutively associated with RAREs and to actively repress transcription in the absence of ligand through association with the corepressors nuclear receptor corepressor or SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) (7) (8) (9) . Nuclear receptor corepressor and SMRT are found in repressor complexes containing the histone deacetylase HDAC3 (10, 11) .
The F9 murine embryonal carcinoma cell line has been extensively used as a cell autonomous model system to study RA signaling. F9 cells resemble the pluripotent stem cells of the inner cell mass of the early embryo and differentiate into three distinct extraembryonic (primitive, parietal, and visceral) endodermal cell types upon treatment with RA, depending on the cell culture conditions (12) . F9 cells express all known RA receptors, but RAR␤ 2 mRNA is only present in high amounts after RA addition (13).
Specific functions for each of the RARs have been demonstrated through the use of F9 cells in which each of the individual RARs has been knocked out by homologous recombination as well as through the use of synthetic isotype-selective ligands. F9 RAR null cells exhibit marked modulation of a variety of genes when compared with the F9 wild type (Wt) cells. For example, the RA-mediated transcription of the homeobox gene Hoxa1 is specifically regulated by RAR␥ because the RA-induced expression of Hoxa1 mRNA is abrogated in F9 RAR␥ Ϫ/Ϫ cells (14) . Additionally a synthetic retinoid selective for RAR␥ can induce expression of Hoxa1 mRNA in F9 Wt cells but not in F9 RAR␥ Ϫ/Ϫ cells (15) . Furthermore RAR␥ Ϫ/Ϫ cells fail to exhibit complete morphological differentiation in culture when treated with RA (14) . Another example of isotype-specific function comes from studies utilizing a F9 RAR␤ 2 Ϫ/Ϫ cell line. In contrast to F9 Wt, RAR␣ Ϫ/Ϫ , and RAR␥ Ϫ/Ϫ cell lines, the F9 RAR␤ 2 Ϫ/Ϫ cell line exhibits no growth arrest in response to RA (16) . Additionally a number of genes specifically regulated by the RAR␤ 2 isoform in F9 cells have been identified through use of subtractive hybridization and DNA array analysis (17) . RAR␣ also specifically regulates RA target genes in F9 cells as the expression of both Hoxb1 and CRABP-II is reduced in F9 RAR␣ Ϫ/Ϫ cells compared with F9 Wt and F9 RAR␥ Ϫ/Ϫ cells (18) . It should be noted that in the F9 RAR null cell lines the expression levels of the undisrupted RARs were similar to those found in F9 Wt cells (19) . These results demonstrate that each of the RAR isotypes regulates a specific subset of target genes in F9 cells when the RAR isotypes are expressed at endogenous levels.
A degree of functional redundancy among the three RAR isotypes has also been demonstrated through use of the F9 RAR null cells and isotype-selective ligands. For example, ϳ10-fold overexpression of RAR␣ in F9 RAR␥ Ϫ/Ϫ cells could restore target gene activation of RAR␥ target genes such as Hoxa1 as well as the differentiation potential of F9 RAR␥ Ϫ/Ϫ cells (20) . In the same set of experiments, however, overexpression of RAR␤ 2 could not restore Hoxa1 mRNA expression in F9 RAR␥ Ϫ/Ϫ cells. Additionally the expression of Hoxa1 mRNA in F9 RAR␥ Ϫ/Ϫ cells could be restored by exposure to an RAR␣-selective ligand (15) . However, this same RAR␣-selective ligand inefficiently induced expression of Hoxa1 mRNA in F9 Wt cells (15) , indicating that the presence of RAR␥ can hinder the ability of RAR␣, bound to an RAR␣-selective agonist, to induce RA target genes. Furthermore an RAR␤-specific agonist could induce expression of another RA target gene, RAR␤ 2 itself, in F9 RAR␥ Ϫ/Ϫ cells but not in F9 Wt or RAR␣ Ϫ/Ϫ cells (15) . These results demonstrate that some of the functional redundancies observed among individual RARs in F9 RAR null cells do not exist in the context of wild type cells.
In this study we used ChIP assays to monitor how the association of RAR␥, RXR␣, and coregulators with the RAREs regulating expression of the Hoxa1 (21), RAR␤2 (22) , and Cyp26A1 (23, 24) genes is affected in the various F9 RAR null cell lines as compared with F9 Wt cells. Additionally we quantitatively monitored the expression of these target genes in the aforementioned F9 cell lines by real time PCR. We demonstrated that RAR␥ was associated with the RAREs that regulate the transcription of the Hoxa1 and Cyp26A1 mRNAs. We also showed that RAR␥ was associated with the RAR␤ 2 RARE even though RAR␥ was not required for the RA-induced expression of RAR␤ 2 mRNA. Furthermore we demonstrated that the presence of RAR␥ and RXR␣ at an RARE was not sufficient for the recruitment of factors required for transcription, such as p300 and pCIP, to the corresponding target genes. We also showed that the levels of the polycomb repressive protein SUZ12 associated with the RAREs monitored in this study were significantly higher in RAR␥ Ϫ/Ϫ cells as compared with F9 Wt and F9 RAR␤ 2 Ϫ/Ϫ cells. Thus, we demonstrated that components of the RAR signaling apparatus were specifically required for displacement of SUZ12 from RAREs during the RA-mediated differentiation of F9 cells.
MATERIALS AND METHODS
Cell Culture-F9 Wt, RAR␣ Ϫ/Ϫ , RAR␤ 2 Ϫ/Ϫ , and RAR␥ Ϫ/Ϫ embryonal carcinoma cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (Invitrogen), 2 mM glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin. Cells were plated in gelatin-coated tissue culture plates ϳ48 h prior to RNA harvesting (5 ϫ 10 5 cells/ 60-mm dish) or formaldehyde fixation (2.5 ϫ 10 6 cells/20-cm dish). Cells were treated with 1 M retinoic acid for 24 h.
Antibodies and Chemicals-All-trans-RA was obtained from Sigma-Aldrich and dissolved in ethanol. Anti-RAR␥ serum was generated by immunization of rabbits with a peptide corresponding to the F region of RAR␥ (NH 2 -PGPHPKASSE-DEAPGGQGKRGQS-COOH). Polyclonal anti-RAR␥ IgG was purified from the crude serum through use of a DEAE Affi-Gel blue gel column (Bio-Rad). Anti-RXR␣ (D-20, sc-553), antipCIP (M-397, sc-9119), anti-p300 (N-15, sc-584), and anti-actin (I-19, sc-1616) antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-SUZ12 (07-379) antibody was purchased from Upstate Biotechnology (Lake Placid, NY). Anti-phospho-Ser-5 carboxyl-terminal domain (CTD) of RNA polymerase II (pCTDser5) was purchased from Covance Research Products (Richmond, CA).
RNA Preparation and RT-PCR-RNA was prepared and subjected to semiquantitative or real time RT-PCR analysis as described previously (25) .
Characterization of F9 RAR␣, -␤ 2 , and -␥ Null Cell Lines-RNA was prepared and subjected to semiquantitative RT-PCR analysis. The primers used to detect RAR␣ spanned the exon in which the disruption cassette was inserted and were as follows: 5Ј-ATCGAGACCCAGAGCAGCAG-3Ј and 5Ј-CCTGGT-GCGCTTTGCGAACC-3Ј (18) . The primers used to detect RAR␥ also spanned the exon in which the disruption cassette was inserted (14) and were as follows: 5Ј-CAATAAG-GAGAGACTCTTTGCG-3Ј and 5Ј-TTGCTGACCTTGGT-GATGAGTT-3Ј. The primers used to detect RAR␤ 2 (16) were as follows: 5Ј-GATCCTGGATTTCTACACCG-3Ј and 5Ј-CACTGACGCCATAGTGGTA-3Ј.
ChIP Assays-ChIP assays were performed as described previously (25) .
Semiquantitative and Real Time PCR-Semi-quantitative PCRs and real time PCRs were performed as described previously (25) .
Western Blot Analysis-Whole cell extracts were prepared from COS cells that were either mock-transfected or transfected with a plasmid expressing RAR␣, RAR␤, or RAR␥. Five micrograms of each of the COS whole cell extracts were resolved by 12% SDS-PAGE followed by transfer to a nitrocellulose membrane (0.45-m pore size; catalog number 162-0090, Bio-Rad). Primary antibody incubation was done overnight at 4°C. The anti-RAR␥ blue eluate, as described above, was used at a 1:200 dilution to detect RAR␥. After a 1-h incubation with an immunoglobulin G horseradish peroxidaseconjugated secondary antibody at room temperature (anti-rabbit, 1:40,000 dilution; sc-2030, Santa Cruz Biotechnology), the membranes were developed with SuperSignal Substrate (Pierce) for 5 min and exposed to BioMax film (Eastman Kodak Co.). Primary and secondary antibodies were diluted in phosphate-buffered saline containing 5% Blotto (Santa Cruz Biotechnology) and 0.1% Tween 20. Blots were stripped with Restore Plus Western Blot Stripping Buffer (Pierce, 46430) and then reprobed with an anti-actin antibody (1:400 dilution) followed by incubation with the appropriate horseradish peroxidase-conjugated secondary antibody (anti-goat, 1:2000 dilution; sc-2056, Santa Cruz Biotechnology).
RESULTS
We have previously studied the association of RAR␥, RXR␣, and other proteins involved in transcriptional regulation with the Hoxa1, RAR␤2, and Cyp26A1 RAREs (R1 and R2) during the course of RA treatment in F9 Wt cells (25) . The main purpose of this study was to determine how the association of RAR␥, RXR␣, and coregulators with the aforementioned RAREs is affected by the absence of each of the three RAR isotypes. Therefore, we utilized F9 cells lines in which both alleles of RAR␣ (18), RAR␤ 2 (the predominant isoform of RAR␤) (16) , and RAR␥ (14) were individually knocked out by homologous recombination.
To confirm that the RAR isotypes were individually knocked out in our cell lines, we monitored expression of the RAR isotypes in the various F9 RAR null cell lines by semiquantitative RT-PCR. F9 Wt and F9 RAR␣ Ϫ/Ϫ , -␤ 2 Ϫ/Ϫ , and -␥ Ϫ/Ϫ cell lines were either untreated or treated with 1 M RA for 24 h, and RNA was harvested. RAR␣ mRNA was detected in RAR␥ Ϫ/Ϫ and RAR␤ 2 Ϫ/Ϫ cells at levels similar to those in F9 Wt cells irrespective of the presence of RA treatment (Fig. 1A) . As expected, no RAR␣ mRNA could be detected in F9 RAR␣ Ϫ/Ϫ cells (Fig. 1A) . The expression of RAR␥ mRNA could not be detected in RAR␥ Ϫ/Ϫ cells, although RAR␥ mRNA was expressed in RAR␣ Ϫ/Ϫ and RAR␤ 2 Ϫ/Ϫ cells at levels similar to those seen in F9 Wt cells irrespective of the presence of RA (Fig.  1A) . In contrast to RAR␣ and RAR␥, the expression of RAR␤ 2 was strongly induced by the presence of RA in F9 Wt cells (Fig.  1A) . RA-induced expression of RAR␤ 2 mRNA was observed in RAR␣ Ϫ/Ϫ and RAR␥ Ϫ/Ϫ cells, and as expected, RAR␤ 2 mRNA could not be detected in RA-treated RAR␤ 2 Ϫ/Ϫ cells (Fig. 1A) . To ensure that equivalent amounts of RNA were used in the RT-PCR assays, expression of the ribosomal phosphoprotein 36B4 "housekeeping gene" (26) was monitored. All samples expressed 36B4 mRNA to similar levels (Fig. 1A) . Thus, we confirmed that the three different RAR null cell lines each specifically lacked expression of one RAR isotype.
RA Induced Expression of Hoxa1, RAR␤ 2 , and Cyp26A1 mRNAs in F9 Wt and RAR Null Cell Lines-We next determined whether Hoxa1, RAR␤ 2 , and Cyp26A1 mRNAs could be induced by RA in the F9 RAR␣, -␤ 2 , and -␥ null cell lines as these three genes are all strongly induced by RA in F9 Wt cells (27) (28) (29) . F9 Wt and the RAR null cell lines were either untreated or treated with 1 M RA for 24 h, and RNA was harvested for use in RT-PCR. Real time PCR was used to quantitate RT-PCR products corresponding to the three RA target genes. As expected, all three RA target genes were strongly induced (Ͼ22-fold) by RA treatment in F9 Wt cells (Fig. 1B) . Again we also monitored the levels of 36B4 mRNA in the F9 Wt, RAR␣
, and RAR␥ Ϫ/Ϫ cell lines. Similar levels of 36B4 mRNA were observed in all of the cell lines both in the presence and absence of RA (Fig. 1B) .
Hoxa1 mRNA levels in RAR␣ Ϫ/Ϫ cells were similar to those seen in F9 Wt cells cultured in the presence or absence of RA (Fig. 1B) (Fig. 1B) . This latter result indicates that in the absence of RA RAR␣ may have a role in the repression of RAR␤ 2 (30) . Levels of Cyp26A1 mRNA after RA treatment of F9 RAR␣ Ϫ/Ϫ cells were ϳ57% of the levels observed in F9 Wt cells (Fig. 1C) , indicating that RAR␣ has a role in the RA-induced expression of this gene.
Previous reports have demonstrated that RAR␥ is required for the expression of both the Hoxa1 (18) and Cyp26A1 (27) genes in F9 Wt cells. Our results are in agreement with these reports as we did not observe expression of either Hoxa1 or Cyp26A1 mRNA in RA-treated F9 RAR␥ Ϫ/Ϫ cells (Fig. 1 , B and C), whereas a Ͼ22-fold induction of these mRNAs was observed in F9 Wt cells. RA-induced expression of RAR␤ 2 also was reduced in RAR␥ Ϫ/Ϫ cells (ϳ43% of F9 Wt) relative to F9 Wt cells (Fig. 1, B and C) . Thus, we concluded that RAR␥ has a prominent role in the regulation of Hoxa1 and Cyp26A1 and a lesser role in the induction of RAR␤ 2 transcripts in response to RA.
As expected, expression of RAR␤ 2 mRNA was abrogated in RAR␤ 2 Ϫ/Ϫ cells as RAR␤ 2 transcripts detected in RAR␤ 2 Ϫ/Ϫ cells were less than 1% of the levels observed in F9 Wt cells (Fig.  1, B and C) . The low levels of RAR␤ 2 transcripts detected in RAR␤ 2 Ϫ/Ϫ cells may represent fusion transcripts generated through the RAR␤ 2 RARE that remains intact in these cells. Additionally the RA-induced expression of Hoxa1 (ϳ28%) and Cyp26A1 (ϳ34%) transcripts was lower in F9 RAR␤ 2 Ϫ/Ϫ cells relative to levels observed in F9 Wt cells (Fig. 1C) , consistent with data from our laboratory (16) .
The Association Patterns of RAR␥ and RXR␣ with the RAREs Regulating Expression of the Hoxa1 Gene in F9 Wt and F9 RAR␣, -␤ 2 , and -␥ Null Cell Lines-We previously demonstrated that RAR␥ and RXR␣, both in the presence and absence of RA, are associated with the RAREs that regulate expression of the Cyp26A1 (R1 and R2), Hoxa1, and RAR␤ 2 genes in F9 Wt cells (25) . These results are consistent with previous studies that have also demonstrated that RAR-RXR heterodimers are constitutively associated with RAREs (31, 32) . In this study we wanted to determine whether the absence of each of the RAR isotypes in F9 cells would affect the association of RAR␥ and RXR␣ with these RAREs. Therefore, we monitored the association of RAR␥ and RXR␣ with the aforementioned RAREs through use of a two-step ChIP assay (33) . F9 Wt and F9 RAR␣, -␤ 2 , and -␥ null cell lines were cultured in the presence or absence of RA for 24 h and then subjected to the protein-protein cross-linking reagent disuccinimidyl glutarate. Cells were then formaldehyde-fixed as in conventional ChIP assays, and soluble chromatin was prepared as described under "Materials and Methods." Antibodies to RAR␥ and RXR␣ were used to immunoprecipitate protein-DNA complexes from soluble chromatin. Nonspecific rabbit IgG antibodies were also used as a negative control in the two-step ChIP assays.
The anti-RAR␥ IgG used in the two-step ChIP assays was generated in our laboratory (see "Materials and Methods"). To determine the specificity of the anti-RAR␥ IgG, we prepared individual COS cell extracts from cells overexpressing each of the RAR isotypes. COS cell extract was also prepared from cells that were mock-transfected. The COS cell extracts were resolved by SDS-PAGE and subsequently subjected to immunoblot analysis against the anti-RAR␥ IgG. The anti-RAR␥ IgG specifically recognized antigen from COS cells overexpressing RAR␥, and the positive signal was at the expected molecular mass for RAR␥ (Fig. 2B ). These results demonstrate that the anti-RAR␥ IgG specifically recognizes the RAR␥ isotype.
The Hoxa1 RARE is located ϳ2 kb downstream of the Hoxa1 gene, whereas the RAR␤2 RARE is located ϳ55 bp upstream of the transcription start site ( Fig. 2A ). Cyp26A1 contains a RARE ϳ70 bp upstream of the transcription start site denoted as R1 (23) as well as a more recently described RARE denoted as R2 (24) found ϳ1950 bp upstream of R1 ( Fig. 2A) . As a control for the nonspecific IP of DNA in ChIP assays, we also measured a gene-free region located Ϫ18 kb downstream of the Hoxb1 gene (Hoxb1 Ϫ18 kb). Levels of these five DNA regions recovered in ChIP assays were quantitated by real time PCR assays. We define -fold enrichment as the percentage of input of a specific locus in an IP divided by the percentage of input of the Hoxb1 Ϫ18 kb 3Ј negative control region in the same IP (Fig. 3) . The data are presented as -fold enrichment to normalize for the higher levels of nonspecific DNA (Hoxb1 Ϫ18 kb 3Ј locus) found in RXR␣ IPs as compared with RAR␥ IPs in the two-step ChIP assays.
The levels of RAR␥ associated with the Hoxa1 RARE in the presence and absence of RA in F9 Wt cells were similar (Fig. 3A , middle panel; ϳ10-fold enrichment). However, the levels of RAR␥ associated with the Hoxa1 RARE increased in F9 RAR␣ Ϫ/Ϫ (ϳ3.5-fold, p value Ͻ0.05) and RAR␤ 2 Ϫ/Ϫ (ϳ2.7-fold, p value Ͻ0.01) cells as a result of RA treatment (Fig. 3A , middle panel). Additionally higher levels of RAR␥ were associated with the Hoxa1 RARE in RAR␣ Ϫ/Ϫ cells (ϳ2.7-fold, p value Ͻ0.05) and in RAR␤ 2 Ϫ/Ϫ cells (ϳ1.7-fold, p value Ͻ0.06) treated with RA as compared with RA-treated F9 Wt cells (Fig.  3A , middle panel). The levels of Hoxa1 RARE DNA immunoprecipitated with RAR␥ when using soluble chromatin derived from RAR␥ Ϫ/Ϫ cells (Fig. 3B , middle and right panels) were comparable to the background levels of Hoxa1 RARE DNA immunoprecipitated with nonspecific rabbit IgG (Fig. 3A , right panel). This result further confirms the isotype specificity of the anti-RAR␥ IgG used in this study.
We also examined the association of RXR␣ with the Hoxa1 RARE in F9 Wt and the F9 RAR␣, -␤ 2 , and -␥ null cell lines (Fig.   3A, left panel (25) high levels of RAR␥ were associated with the Cyp26A1 R2 RARE in the absence and presence of RA in F9 Wt cells (Fig. 3B, middle  panel) . The levels of RAR␥ associated with the R2 RARE in the F9 RAR␣ null and F9 RAR␤ 2 null cells were similar to the levels observed in F9 Wt cells (Fig. 3B, middle panel) . Again the Cyp26A1 R2 RARE was not detected in RAR␥ IPs utilizing soluble chromatin derived from F9 RAR␥ Ϫ/Ϫ cells; only backgrounds levels were seen (Fig. 3B, middle panel) .
The levels of RXR␣ associated with the Cyp26A1 R2 RARE in F9 RAR␤ 2 null and RAR␣ null cells were similar to those seen in F9 Wt cells (Fig. 3B, left panel) . Therefore, although RAR␥ is required for expression of Cyp26A1 (Fig. 1B) , RXR␣ can still associate with the R2 RARE in the absence of RAR␥ presumably as a heterodimer with RAR␤ 2 or RAR␣. This result suggests that RAR␤ 2 -RXR␣ or RAR␣-RXR␣ heterodimers bound at the R2 RARE are not able to transduce a RA signal, culminating in transcription of the Cyp26A1 gene, in response to RA. Similar patterns of association of RXR␣ and RAR␥ with the Cyp26A1 R1 RARE compared with the R2 RARE were observed, although -fold enrichment levels were lower at the R1 RARE compared with the R2 RARE (Fig. 3, B and C) .
We wanted to address whether RAR␥ associates with the RAR␤ 2 RARE in F9 RAR␤ 2 Ϫ/Ϫ cells even though these cells do not express RAR␤ 2 mRNA in response to RA (Fig. 1, B and C) . In contrast to the Hoxa1 and Cyp26A1 genes, RAR␥ was not required for transcription of RAR␤ 2 , although RA-induced expression levels of RAR␤ 2 were reduced in RAR␥ Ϫ/Ϫ cells as compared with F9 Wt cells (Fig. 1, B and C) . RAR␥ was associated with the RAR␤ 2 RARE in both the presence and absence of RA (Fig. 3D, middle panel) in F9 Wt cells. Additionally the levels of RAR␥ associated with the RAR␤ 2 RARE in the F9 RAR␤ 2 null and F9 RAR␣ null cell lines were comparable to the levels seen in the F9 Wt cells (Fig. 3D, middle panel) . Therefore, we have demonstrated that RAR␥ associated with the RAR␤ 2 RARE is incapable of transducing the RA signal required for expression of RAR␤ 2 transcripts in the absence of RAR␤ 2 protein.
We also determined whether the association level of RXR␣ with the RAR␤ 2 RARE is perturbed in F9 RAR␤ 2 Ϫ/Ϫ cells as compared with F9 Wt, F9 RAR␥ Ϫ/Ϫ , and F9 RAR␣ Ϫ/Ϫ cells. In contrast to RAR␥, lower levels of RXR␣ were associated with the RAR␤ 2 RARE, both in the presence (ϳ43% of Wt) and absence (ϳ25% of Wt) of RA, in F9 RAR␤ 2 Ϫ/Ϫ cells as compared with F9 Wt cells (Fig. 3D , left panel; p value Ͻ0.05 for both comparisons). Additionally the levels of RXR␣ associated with the RAR␤ 2 RARE were lower in the F9 RAR␤ 2 Ϫ/Ϫ cells as compared with the F9 RAR␣ and ␥ null cell lines (Fig. 3D, left  panel) . Therefore, the absence of RAR␤ 2 impedes the association of RXR␣ with the RAR␤ 2 RARE, consistent with previous reports that demonstrated an autoregulatory role for the RAR␤ 2 protein (15, 20, 35) .
RA-mediated Recruitment of pCIP and p300 to the RAREs That Regulate Expression of the Hoxa1 and Cyp26A1 Genes Is Compromised in F9 RAR␥
Ϫ/Ϫ Cells as Compared with F9 Wt and RAR␤ 2 Ϫ/Ϫ Cells-We demonstrated that RAR␥ was required for the RA-induced expression of Hoxa1 and Cyp26A1 mRNAs (Fig. 1, B and C) in F9 cells. Additionally we showed that RAR␤ 2 transcripts were not expressed in F9 RAR␤ 2 Ϫ/Ϫ cells. Therefore, we wanted to examine whether the recruitment of coregulators to the RAREs regulating the aforementioned genes is perturbed in F9 RAR␤ 2 Ϫ/Ϫ and F9 RAR␥ Ϫ/Ϫ cell lines. We were able to utilize conventional one-step ChIP assays to monitor the association of the p160 coactivator pCIP (also referred to as AIB1/ACTR/RAC-3/TRAM-1/SRC-3) (36) as well as the histone acetyltransferase coactivator p300 (37) to the RAREs in the F9 RAR␤ 2 Ϫ/Ϫ and F9 RAR␥ Ϫ/Ϫ cell lines as well as in the F9 Wt cells.
Consistent with our previous results (25) , the levels of pCIP associated with the Hoxa1 RARE rose ϳ4.3-fold in F9 Wt cells as a result of RA treatment (Fig. 4A, left panel) . The levels of pCIP associated with the Hoxa1 RARE in untreated and RAtreated RAR␤ 2 Ϫ/Ϫ cells were similar to those seen in F9 Wt cells (Fig. 4A, left panel) , although the RA-induced expression of Hoxa1 mRNA was reduced in F9 RAR␤ 2 Ϫ/Ϫ cells to ϳ25% of the level observed in F9 Wt cells (Fig. 1, B and C) . However, in F9 RAR␥ Ϫ/Ϫ cells, which do not express Hoxa1, the levels of pCIP associated with the Hoxa1 RARE were reduced both in the absence (ϳ3-fold) and presence (ϳ4-fold) of RA relative to F9 Wt cells (Fig. 4A, left panel) . Additionally the levels of pCIP associated with the Hoxa1 RARE in RA-treated F9 RAR␥ Ϫ/Ϫ cells were similar to the basal levels of pCIP associated with the Hoxa1 RARE in F9 Wt and F9 RAR␤ 2 Ϫ/Ϫ cells (Fig. 4A, left  panel) . Therefore, we concluded that coactivators are not recruited by RAR-RXR heterodimers bound at the Hoxa1 RARE in F9 RAR␥ Ϫ/Ϫ cells treated with RA. We also monitored pCIP association with the Cyp26A1 R1 RARE located immediately upstream of the Cyp26A1 transcription start site (Fig. 2A) . The recruitment patterns of pCIP to the Cyp26A1 R1 RARE in the three F9 cell lines were similar to those seen for the Hoxa1 RARE (Fig. 4A, compare left panel and  middle panel) . The levels of pCIP associated with the Cyp26A1 R1 RARE rose in the F9 Wt by ϳ3.9-fold and in F9 RAR␤ 2 Ϫ/Ϫ cells by ϳ5.4-fold as a result of RA treatment, and this RAassociated increase was not observed in the F9 RAR␥ Ϫ/Ϫ cell line (Fig. 4A, middle panel) . Therefore, we concluded that recruitment of pCIP to the RAREs that regulate the transcription of Hoxa1 and Cyp26A1 requires RAR␥. Furthermore the lack of RA-induced recruitment of pCIP to the Hoxa1 and Cyp26A1 RAREs likely explains why these genes are not expressed in RAR␥ Ϫ/Ϫ cells. The levels of p300 increased at both the Hoxa1 (ϳ6.9-fold) and Cyp26A1 R1 (ϳ4-fold) RAREs in F9 Wt cells as a result of RA treatment (Fig. 4B, left and middle panels) . Additionally comparable levels of p300 were associated with the Hoxa1 and Cyp26A1 R1 RAREs in F9 RAR␤ 2 Ϫ/Ϫ cells as compared with F9 Wt cells both in the absence and presence of RA (Fig. 4B , left and middle panels). In contrast, RA-associated p300 recruitment to the Hoxa1 RARE was reduced by ϳ4. 5 (Fig. 1, B and C) . Thus, we monitored the association of pCIP and p300 with the RAR␤ 2 RARE in F9 Wt, RAR␤ 2 Ϫ/Ϫ , and RAR␥ Ϫ/Ϫ cell lines. The levels of p300 associated with the RAR␤ 2 RARE increased ϳ2.3-fold (p value Ͻ0.08) as a result of RA treatment in F9 Wt cells (Fig. 4B, right panel) . Levels of p300 also increased at the RAR␤ 2 RARE by ϳ1.8-fold as a result of RA treatment (p value Ͻ0.05) in the F9 RAR␥ Ϫ/Ϫ cell line. The high basal levels of pCIP and p300 observed at the RAR␤ 2 RARE are consistent with a previous study that demonstrated that much of the transcriptional machinery is associated with the RAR␤ 2 RARE in P19 embryonal carcinoma cells prior to RA treatment (32) . In contrast, we did not observe an RAinduced increase of p300 at the RAR␤ 2 RARE in the F9 RAR␤ 2 Ϫ/Ϫ cell line (Fig. 4B, right panel) , although the basal level of p300 associated with the RAR␤ 2 RARE was higher in RAR␤ 2 Ϫ/Ϫ cells than in the F9 Wt (p value Ͻ0.01) and the F9 RAR␥ Ϫ/Ϫ cell lines (p value Ͻ0.01). Recruitment patterns of pCIP to the RAR␤ 2 RARE mirrored those seen for p300 in the three cell lines (compare Fig. 4B, right panel, with Fig. 4A, right  panel) . The fact that p300 and pCIP levels did not increase as a result of RA treatment at the RAR␤ 2 RARE in the F9 RAR␤ 2 Ϫ/Ϫ cell line indicates that RAR␤ 2 protein itself is required to increase the levels of the coregulators necessary for RAR␤ 2 transcription.
Levels of RNA Polymerase II Associated with Transcription Initiation Were Reduced at the RAREs Regulating Expression of the Hoxa1 and Cyp26A1 Genes in F9 RAR␥ Ϫ/Ϫ Cells as Compared with F9 Wt and RAR␤ 2
Ϫ/Ϫ Cells-We also determined how the association of the initiating form of RNA polymerase II (initiating pol II) with the RAREs monitored in this study is perturbed in the F9 RAR␤ 2 Ϫ/Ϫ and the F9 RAR␥ Ϫ/Ϫ cell lines as compared with F9 Wt cells. We monitored the association of pol II by using an antibody that recognizes phosphorylated serine 5 of the CTD of initiating pol II (38) . In other systems, serine 5 phosphorylation of the CTD has been associated with transcriptional initiation (39) . Similar basal levels of initiating pol II were associated with the Hoxa1 RARE in F9 Wt, F9 RAR␤ 2 Ϫ/Ϫ , and F9 RAR␥ Ϫ/Ϫ cells (Fig. 5A, left panel, 0 Wt cells with RA resulted in a ϳ9.3-fold (p value Ͻ0.02) increase in the levels of initiating pol II associated with the Hoxa1 RARE. In the F9 RAR␤ 2 Ϫ/Ϫ cells, RA treatment resulted in a similar increase (ϳ8.7-fold) in the levels of initiating pol II associated with the Hoxa1 RARE as compared with F9 Wt cells (Fig. 5A, left panel) . However, in the F9 RAR␥ Ϫ/Ϫ cell line, initiating pol II levels rose only ϳ1.7-fold at the Hoxa1 RARE after RA treatment. Additionally the levels of initiating pol II associated with the Hoxa1 RARE in the F9 RAR␥ Ϫ/Ϫ cells never rose above the basal levels observed at this RARE in F9 Wt cells (Fig.  5A, left panel) . These results suggest that in the absence of RAR␥, RAR (␣ ϩ ␤)-RXR␣ heterodimers (Fig. 3A) bound at the Hoxa1 RARE are unable to associate and/or increase the levels of initiating pol II in response to RA treatment. Cell Line (Fig. 5A, middle panel) . Therefore, in the absence of RAR␥, the RAR (␣ ϩ ␤)-RXR heterodimers bound at the Cyp26A1 RAREs (Fig. 3, B and C) were also unable to recruit and/or increase the levels of initiating pol II efficiently in response to RA treatment.
Differences in the Association of Initiating pol II with the RAR␤ 2 RARE in F9 RAR␤ 2 Ϫ/Ϫ Cells as Compared with F9 Wt and F9 RAR␥
Ϫ/Ϫ Cells-The recruitment patterns of initiating pol II to the RAR␤ 2 RARE in the F9 Wt, RAR␤ 2 Ϫ/Ϫ , and RAR␥ Ϫ/Ϫ cells were different from those seen for the Hoxa1 and Cyp26A1 RAREs. In contrast to the levels of initiating pol II recruitment observed for the Hoxa1 and Cyp26A1 RAREs, the increase in initiating pol II recruited to the RAR␤ 2 RARE in RA-treated F9 RAR␥ Ϫ/Ϫ cells was ϳ5.4-fold (p value Ͻ0.02), and this increase was similar to the ϳ4-fold increase (p value Ͻ0.02) in levels of initiating pol II recruited to the RAR␤ 2 RARE in F9 Wt cells (Fig. 5A, right panel) . No RA-mediated increase in initiating pol II associated with the RAR␤ 2 RARE was observed in the F9 RAR␤ 2 Ϫ/Ϫ cells, and these data are consistent with the observation that RAR␤ 2 transcripts were not expressed in F9 RAR␤ 2 Ϫ/Ϫ cells (Fig. 5A, right panel) . The high basal levels of initiating pol II associated with the RAR␤ 2 RARE in the three cell lines studied are consistent with previous reports (32, 40) . We concluded that although RAR␥ was associated with the RAR␤ 2 RARE in F9 RAR␤ 2 Ϫ/Ϫ cells (Fig. 3D ) the presence of RAR␥ is not sufficient for RA-mediated recruitment and/or increase in the levels of initiating pol II (Fig. 5A) or the RA-induced transcription of the RAR␤ 2 gene (Fig. 1, B  and C) .
The Polycomb Group Protein SUZ12 Is Not Efficiently Displaced from the Hoxa1 and Cyp26A1 R1 RAREs in F9 RAR␥

Ϫ/Ϫ
Cells in Response to RA-We have previously shown that the polycomb group protein SUZ12 is associated with the Hoxa1, Cyp26A1 R1, and RAR␤ 2 RAREs in F9 Wt cells and that dissociation of SUZ12 occurs upon exposure to RA (25) . Polycomb proteins have been shown to negatively regulate Hox genes (41) (42) (43) , and the association of SUZ12 with numerous RAREs suggests that polycomb proteins may have a more global role in the repression of RA target genes. We therefore addressed the question of whether there were differences in the association patterns of SUZ12 with the Hoxa1, Cyp26A1, and RAR␤ 2 RAREs in the F9 RAR␤ 2 Ϫ/Ϫ and F9 RAR␥ Ϫ/Ϫ cell lines as compared with F9 Wt cells.
The levels of SUZ12 associated with the Hoxa1 RARE in F9 Wt cells decreased ϳ33-fold in response to RA treatment (Fig.  5B, left panel) . An ϳ8.3-fold decrease in the level of SUZ12 associated with the Hoxa1 RARE was seen in F9 RAR␤ 2 Ϫ/Ϫ cells after RA treatment. Although the basal levels of SUZ12 associated with the Hoxa1 RARE were similar in F9 Wt and F9 RAR␤ 2 Ϫ/Ϫ cells (Fig. 5B, left panel, 0 h ), RA treatment caused a ϳ3.4-fold greater decrease in the levels of SUZ12 associated with the Hoxa1 RARE in F9 Wt cells as compared with F9 RAR␤ 2 Ϫ/Ϫ cells (Fig. 5B , left panel, 24 h; p value Ͻ0.01). The basal levels of SUZ12 associated with the Hoxa1 RARE in F9 RAR␥ Ϫ/Ϫ cells were also statistically similar to the basal levels of SUZ12 associated with this RARE in F9 Wt cells (Fig.  5B, left panel, 0 h ; p value Ͼ0.10). However, ϳ26-fold lower levels of SUZ12 remain associated with the Hoxa1 RARE in F9 Wt cells as compared with F9 RAR␥ Ϫ/Ϫ cells after RA treatment (Fig. 5B, left panel, 24 h ). In fact, the level of SUZ12 associated with the Hoxa1 RARE in RA-treated F9 RAR␥ Ϫ/Ϫ cells was similar to (Ͻ2-fold difference) the level seen in untreated F9 RAR␥ Ϫ/Ϫ cells (Fig. 5A, left panel; p value Ͻ0.05). The association patterns of SUZ12 with the Cyp26A1 R1 RARE before and after RA treatment in the F9 Wt, RAR␤ 2 Ϫ/Ϫ , and RAR␥ Ϫ/Ϫ cell lines were as follows. The basal levels of SUZ12 associated with the Cyp26A1 R1 were similar in the three F9 cell lines (Fig. 5B, middle panel, 0 h ). However, after RA treatment the levels of SUZ12 associated with the Cyp26A1 R1 RARE were ϳ18.3-fold lower in F9 Wt cells than in F9 RAR␥ Ϫ/Ϫ cells (p value Ͻ0.0001) and ϳ2.7-fold lower in F9 Wt cells as compared with F9 RAR␤ 2 Ϫ/Ϫ cells (Fig. 5B , middle panel, 24 h; p value Ͻ0.01).
These results demonstrate that the addition of RA does not result in the efficient displacement of SUZ12 from the Hoxa1 and Cyp26A1 RAREs in F9 RAR␥ Ϫ/Ϫ cells. Additionally the levels of SUZ12 displaced from the Hoxa1 RARE after RA treatment in the three cell lines were inversely related to the expression levels of Hoxa1 in these same lines. Whereas transcription of Hoxa1 was strongly induced by RA in F9 Wt cells, transcription of Hoxa1 was reduced by ϳ50% in F9 RAR␤ 2 Ϫ/Ϫ cells, and it was almost completely abrogated in the F9 RAR␥ Ϫ/Ϫ cell line (Fig. 1A) . Conversely after RA treatment the highest levels of SUZ12 were associated with the Hoxa1 RARE in the RAR␥ Ϫ/Ϫ cells with lower levels in F9 RAR␤ 2 Ϫ/Ϫ cells and the lowest level in the F9 Wt cells (Fig. 5A, left panel ). An inverse relationship between the expression of Cyp26A1 mRNA in the three cell lines and the level of SUZ12 associated with the Cyp26A1 R1 RARE in these three same cell lines was also observed (Fig. 1, B and C, and Fig. 5A, middle panel) .
The Levels of SUZ12 Associated with the RAR␤ 2 RARE Correlate with Transcription and the Presence of RAR␥-The levels of SUZ12 associated with the RAR␤ 2 RARE decreased ϳ3.4-fold (p value Ͻ0.01) in F9 Wt cells and ϳ7.9-fold (p value Ͻ0.06) in the F9 RAR␥ Ϫ/Ϫ cell line after exposure to RA (Fig.  5B, right panel) . However, in the F9 RAR␤ 2 Ϫ/Ϫ cell line, which does not express RAR␤ 2 transcripts, an RA-dependent decrease in association of SUZ12 with the RAR␤ 2 RARE was not observed (Fig. 5A, right panel) . Therefore, these results indicate that RA-associated transcription of the RAR␤ 2 gene is correlated with the displacement of SUZ12 from the RAR␤ 2 RARE.
Interestingly higher levels of SUZ12 were associated with the RAR␤ 2 RARE in untreated F9 RAR␥ Ϫ/Ϫ cells as compared with untreated F9 RAR␤ 2 Ϫ/Ϫ cells (p value Ͻ0.06) and untreated F9 Wt cells (p value Ͻ0.06). Additionally the levels of SUZ12 that were associated with the RAR␤ 2 RARE were similar in RA-treated RAR␥ Ϫ/Ϫ cells and RA-treated F9 RAR␤ 2 Ϫ/Ϫ cells (Fig. 5B, right panel, 24 h ), although transcription of RAR␤ 2 mRNA was higher in RA-treated RAR␥ Ϫ/Ϫ cells as compared with RA-treated F9 RAR␤ 2 Ϫ/Ϫ cells (Fig. 1, B and C) . Furthermore the levels of SUZ12 associated with the RAR␤ 2 RARE were ϳ3.5-fold higher in RA-treated F9 RAR␥ Ϫ/Ϫ cells as compared with RA-treated F9 Wt cells (Fig. 5B, 24 h; p value Ͻ0.01). Therefore, irrespective of the transcriptional status of a gene, the levels of SUZ12 associated with a RARE may be influenced by the presence of RAR␥. The binding of RAR␥ to a RARE may block the association of SUZ12 with the aforementioned RARE. In the absence of RAR␥, higher levels of SUZ12 may be able to associate with a RARE.
DISCUSSION
Previous studies have demonstrated that the RAR␣, -␤ 2 , and -␥ isotypes each regulate a specific subset of target genes (44) . In this study, we used chromatin immunoprecipitation assays to monitor the association of RAR␥, RXR␣, and other proteins involved in transcription with the RAR␤ 2 , Hoxa1, and Cyp26A1 RAREs in F9 Wt cells. We then monitored the association patterns of these factors to the aforementioned RAREs in F9 RAR␣, -␤ 2 , and -␥ null cell lines and compared these results to what was observed in the F9 Wt cells. Additionally we determined the expression of the corresponding target genes in the F9 Wt and the F9 RAR␣, -␤ 2 , and -␥ null cell lines via quantitative real time RT-PCR. By using this approach we were able to demonstrate that the association of RAR␥ and/or RXR␣ with a RARE does not suffice for the RA-mediated transcription of the corresponding target gene. However, the ability of RAR␥ and/or RXR␣ to recruit the coactivators pCIP and p300 to an RARE did correlate with the RA-mediated transcription of the corresponding target mRNAs. Additionally the ability of RAR␥ and/or RXR␣ to recruit and/or increase the levels of initiating RNA polymerase II to a RARE in response to RA mirrored the ability to recruit pCIP and p300. From these results we conclude that the specific functions of the RAR isotypes do not manifest at the level of DNA binding but rather from a differential ability to recruit specific components of the transcriptional machinery. We also demonstrated that the RA-mediated displacement of SUZ12 from a RARE was greatly inhibited in the absence of RAR␥. Thus we demonstrated that components of the RAR signaling machinery are specifically required for the displacement of SUZ12 from RAREs during the RA-mediated differentiation of F9 cells.
RAR Isotype-specific Function Does Not Manifest at the Level of DNA Binding-RAR-RXR heterodimers bind to RAREs, which are composed typically of two direct repeats of a core hexameric motif, PuG(G/T)TCA where Pu is a purine, spaced by 5 bp (referred to as DR5) or less commonly 2 bp (DR2) (6) . The DNA binding domain is the most highly conserved region among the RAR isotypes (6) . In vitro studies have demonstrated that RAR isotypes can bind to the same sequences as each RAR isotype could bind to the Hoxa1/RAR␤ 2 RARE in gel shift mobility assays (14, 20) . Additionally although the RA-induced expression of Hoxa1 and RAR␤2 mRNAs is regulated by the same DR5 element ( Fig. 2A) , expression of Hoxa1 in F9 cells requires RAR␥, whereas RAR␤ 2 is required for its own expression (Fig. 1, B and C) . These results suggest that each of the RAR isotypes has the ability to associate with a given RARE and that the specific functions of a RAR do not manifest at the level of DNA binding. Consistent with this conclusion, we demonstrated that RXR␣, presumably bound as a heterodimer with RAR␣ or RAR␤, was associated with the Hoxa1 and Cyp26A1 RAREs in F9 RAR␥ Ϫ/Ϫ cells (Fig. 3, A, B , and C, left panels) even though these two genes are not induced by RA in this cell line (Fig. 1, B and C) . Additionally we showed that RAR␥ was associated with the RAR␤ 2 RARE in F9 Wt, F9 RAR␣ Ϫ/Ϫ , and F9 RAR␤ 2 Ϫ/Ϫ cells (Fig. 3D, middle panel) even though RAR␥ was not required for the expression of RAR␤ 2 mRNA (Fig. 1, B  and C) .
Future ChIP studies using antibodies specific for the RAR␣ and RAR␤ isotypes could be used to test our conclusion further that each of the RAR isotypes can bind to a given RARE. We unsuccessfully tried numerous commercially available RAR␣ and RAR␤ antibodies in our ChIP studies. Unfortunately these antibodies generated a signal in the corresponding F9 RAR null cell line comparable to what was seen in the F9 Wt cell line, or the antibodies generated a signal that was not sufficiently above background levels. Thus, we were unable to show definitively that RAR␣ and/or RAR␤ 2 were associated with the Hoxa1 and Cyp26 RAREs in F9 RAR␥ Ϫ/Ϫ cells. Previous studies have shown that RAR␤ is required for the RA-associated transcription of Cyp26 mRNA in P19 embryonal carcinoma cells. We showed that neither RAR␣ nor RAR␤ 2 was required for expression of Cyp26A1 in F9 cells, whereas RAR␥ was required for the expression of Cyp26A1 mRNA (Fig. 1, B  and C) . However, previous studies indicate that the functional roles of RAR isotypes in different cell types vary (20, 35) . The molecular mechanisms governing the differential requirement of the RAR isotypes in the regulation of Cyp26A1 in P19 and F9 cells remain to be determined.
RA-mediated Coactivator Recruitment to RAREs
Is an RAR Isotype-specific Event-We also monitored the association of the coactivators pCIP and p300 with the Hoxa1, Cyp26A1 (R1), and RAR␤ 2 RAREs. The levels of pCIP and p300 associated with these RAREs increased as a result of RA treatment in F9 Wt cells (Fig. 4, A and B) . However, RA-mediated increases in the levels of pCIP and p300 associated with a particular RARE were not observed if the corresponding target genes were not transcribed in the F9 RAR null cells. Additionally we demonstrated that RXR␣ was associated with the Hoxa1 and Cyp26A1 R1 RAREs, presumably bound as heterodimers with RAR (␣ ϩ ␤) in RAR␥ Ϫ/Ϫ cells, even though Hoxa1 and Cyp26A1 mRNAs are not transcribed RAR␥ Ϫ/Ϫ cells. Therefore, we have shown that the association of RAR-RXR heterodimers with an RARE is not sufficient for the recruitment of factors required for subsequent transcription. We conclude that specific functional roles for RAR isotypes arise from a differential ability to recruit specific components of the transcriptional machinery. Future studies could address whether the recruitment of other coactivators to RAREs by RAR-RXR heterodimers are also compromised in the RAR null cell lines.
There is precedent for the proposal that RARs interact with coregulators in an isotype-specific manner. RAR␣ has been shown to strongly interact with the nuclear corepressor SMRT in the absence of ligand, whereas unliganded RAR␤ and RAR␥ only weakly interact with SMRT (30) . The inability of RAR␤ and RAR␥ to interact with SMRT results from intramolecular interactions between helix 3 and helix 12 of the hormone binding domains of these isotypes, which occlude corepressor binding (45) . RAR␣ differs from RAR␤ and RAR␥ at three residues in helix 3, which prevents the interaction of helix 3 with helix 12 in RAR␣ (45) . As a result, the corepressor docking site is exposed in RAR␣. Transient reporter assays were used to demonstrate that in the absence of RA RAR␣ is the only RAR isotype that can repress transcription (46) . RAR␤ and RAR␥ actually mediated substantial levels of transcriptional activation in the absence of ligand in this same report (30) . These results illustrate how coregulator recruitment by RAR can differ between isotypes.
A differential ability to recruit coactivators has also been demonstrated for the estrogen receptors (ERs), which consist of two isotypes, ER␣ and ER␤ (47) . Glutathione S-transferase interaction assays were used to demonstrate that ligand-dependent differences exist between ER␣ and ER␤ in their ability to interact with the coactivators TIF2 and SRC1a despite the similarity in binding affinity of the various ligands used in the study for both ER subtypes (48) . However, other groups have demonstrated that certain compounds show ER receptor selectivity with regard to ligand binding and/or efficacy (47) , similar to the development of synthetic retinoids selective for each of the RAR isotypes.
The peroxisome proliferator-activated receptor class of nuclear receptors is similar to RARs in that there are three isotypes, PPAR␣, PPAR␥, and PPAR␦, all of which can bind to similar DNA sequences as heterodimers with RXRs (49) . Each of the PPAR isotypes regulates the expression of distinct but overlapping sets of target genes (50) . Additionally analysis of chimeric PPAR receptors points to the amino terminus of each receptor as the key determinant of isotype-selective gene expression. For example, the amino terminus of PPAR␥ confers the ability to promote adipocyte differentiation when fused to the PPAR␦ DNA binding domain and ligand binding domain. Therefore, RAR isotype specificity may also, in part, arise from differences in the amino termini among RAR isotypes.
RAR Isotype-dependent Association of the Initiating Form of RNA Polymerase II to RAREs Mirrors the Recruitment Patterns of p300 and pCIP-We showed that the RA-mediated increase in the level of initiating pol II associated with an RARE was correlated with the transcription levels of the corresponding target gene. Initiating pol II levels increased in response to RA at the Hoxa1 RARE and Cyp26A1 R1 RARE in F9 Wt and F9 RAR␤ 2 Ϫ/Ϫ cells but not in F9 RAR␥ Ϫ/Ϫ cells (Fig. 5A ). Conversely initiating pol II levels rose at the RAR␤ 2 RARE in F9 Wt and F9 RAR␥ Ϫ/Ϫ cells in response to RA but not in F9 RAR␤ 2 Ϫ/Ϫ cells (Fig. 5A, right panel) . The RA-mediated recruitment of initiating pol II to the target RAREs also correlated with the RA-mediated recruitment of p300 and pCIP to the same RAREs. We note that in F9 Wt cells the association patterns of pol II with target RAREs in ChIP assays using an antibody that recognizes the largest subunit of pol II were similar to the results obtained with the antibody that recognizes the initiating form of pol II. Previous studies implementing in vitro transcription assays have demonstrated that RAR-RXR heterodimers recruit p300 and pCIP prior to pol II and that p300 and p160 recruitment is essential for RA-mediated transcription (31, 51) . Additionally p300 is essential for the RA-mediated differentiation of F9 cells (52) . Our results are consistent with the observation that p300 and pCIP are required for the association and/or increase in the levels of initiating pol II during RA-mediated transcription. (25) . In this study we demonstrated that SUZ12 levels remained high at the Hoxa1 and Cyp26A1 R1 RAREs in RA F9 RAR␥ Ϫ/Ϫ cells after RA treatment as compared with RA-treated F9 Wt and F9 RAR␤ 2 Ϫ/Ϫ cells (Fig. 5B,  24 h ). Additionally Hoxa1 and Cyp26A1 mRNAs were not transcribed in RA-treated RA F9 RAR␥ Ϫ/Ϫ cells (Fig. 1, B and C) . Therefore the question arises as to whether transcription is a prerequisite for the displacement of SUZ12 from RAREs after RA treatment. This could be tested by abolishing transcription of Hoxa1 mRNA in F9 Wt cells through mutation of the Hoxa1 TATA box and monitoring the association of SUZ12 with the Hoxa1 RARE and Hoxa1 promoter-proximal region before and after RA treatment. If RARs recruit the polycomb group complexes directly to RAREs then we would expect SUZ12 to be displaced from the Hoxa1 RARE in the absence of transcription. Alternatively if transcription of Hoxa1 mRNA is required for the displacement of SUZ12, then SUZ12 levels should remain high at the Hoxa1 RARE after RA treatment in a cell line that has a mutated Hoxa1 TATA box.
SUZ12 Is Not Efficiently
We observed comparable levels of SUZ12 associated with the RAR␤ 2 RARE after RA treatment in RAR␥ Ϫ/Ϫ cells and F9 RAR␤ 2 Ϫ/Ϫ cells. However, significantly higher levels of RAR␤ 2 transcripts were expressed in the F9 RAR␥ Ϫ/Ϫ cell line (Fig. 1 , B and C) as compared with the F9 RAR␤ 2 Ϫ/Ϫ cell line. Therefore, the levels of SUZ12 associated with a RARE do not necessarily correlate to the transcription levels of the corresponding target gene. These results are consistent with a report demonstrating that SUZ12 associated with actively transcribed genes during differentiation of mouse embryonic stem cells (53) . Additionally SUZ12 has been shown to associate with transcribed genes prior to and during their down-regulation in human embryonic fibroblasts induced to differentiate by RA (54) .
The fact that RAR␤ 2 mRNA was transcribed in RA-treated F9 RAR␥ Ϫ/Ϫ cells even though comparable levels of SUZ12 were associated with the RAR␤ 2 RARE in F9 RAR␥ Ϫ/Ϫ cells and F9 RAR␤ 2 Ϫ/Ϫ cells (in which RAR␤ 2 mRNA is not expressed) suggests that SUZ12 does not have a prominent role in the repression of RAR␤ 2 transcription. Consistent with this hypothesis, higher levels of SUZ12 were associated with the Hoxa1 and Cyp26A1 R1 RAREs as compared with the RAR␤ 2 RARE. Approximately 1.0% of the Hoxa1 RARE input and ϳ2.7% of the Cyp26A1 R1 RARE input were immunoprecipitated in SUZ12 ChIP assays with soluble chromatin derived from untreated F9 Wt cells as compared with 0.1% of the RAR␤ 2 RARE input. Therefore the association parameters of SUZ12 with the RAR␤ 2 RARE may be different from those seen for SUZ12 with the Hoxa1 and Cyp26A1 R1 RAREs.
It remains to be determined how SUZ12 is targeted to RAR␤ 2 , Hoxa1, and Cyp26A1 RAREs in F9 cells and how mechanistically SUZ12 is displaced from these RAREs upon RA treatment. As we discussed previously, the association of PcG proteins with RA target genes may arise through interactions with RAR-RXR heterodimers (25) . Support for such a model comes from a recent study demonstrating that the human tumor antigen PRAME (preferentially expressed antigen in melanoma) can bind to ligand-bound RAR and repress transcription through recruitment of PcG proteins (55) . Additionally the authors showed that stable expression of PRAME in F9 cells blocked RA-induced differentiation and inhibited RA-induced gene expression. In the context of wild type F9 cells, we posit that an as yet unidentified protein may simultaneously interact with PcG proteins and RAR-RXR heterodimers in the absence of RA, allowing for the recruitment of PcG proteins to RA target genes.
Alternatively SUZ12 may be displaced from RAREs after RA treatment in F9 cells due to an undefined feature of the differentiation process. It has been demonstrated that SUZ12 disassociates from numerous genes during RA-mediated neuronal differentiation of the human embryonal carcinoma cell line NT2/D1 (54) . Moreover SUZ12 disassociation from target genes, resulting in the derepression of these genes during differentiation, has also been observed in murine (53, 56) and human (57) embryonic stem cells. However, our results clearly demonstrate that components of the RAR signaling apparatus are involved in the displacement of SUZ12 because SUZ12 was not displaced from the Hoxa1 and Cyp26A1 RAREs after RA treatment in the absence of RAR␥ (Fig. 5B) . Additionally SUZ12 mRNA levels did not decrease during the RA-mediated differentiation of F9 cells (data not shown). Furthermore SUZ12 reassociates with the Hoxa1 and Cyp26A1 RAREs when RA is removed from the media of F9 Wt cells (25) , demonstrating that some of the molecular events underlying the differentiation process are reversible.
The results of this study demonstrate that components of the RAR signaling apparatus are required for the displacement of SUZ12 from RAREs during the RA-mediated differentiation of F9 Wt cells. We present a model for how SUZ12 may be displaced from the Hoxa1 locus in response to RA (Fig. 6) . Previous studies have demonstrated that SUZ12 can bind throughout the whole Hox A cluster domain in F9 cells (58) as well as in human embryonic stem cells (57) . Additionally we have shown that SUZ12 is associated with the 3Ј Hoxa1 RARE and Hoxa1 promoter-proximal region (25) . Therefore, we depict SUZ12 covering the whole Hoxa1 locus. Based on the results of this study, we propose that the RAR␥ isotype is specifically required for the RA-mediated displacement of SUZ12 from the Hoxa1 gene. In response to RA, RAR␥ can recruit pCIP and p300 to the Hoxa1 RARE, whereas the RAR␣ and RAR␤ isotypes are unable to do so. The RA-dependent recruitment of pCIP and p300 by RAR␥-RXR to the Hoxa1 RARE allows for the subsequent recruitment and/or increase in the levels of initiating pol II to the 3Ј Hoxa1 RARE. Factors associated with the 3Ј Hoxa1 RARE are then able to communicate with initiating pol II prebound to the Hoxa1 promoter region (25) , culminating in transcription of Hoxa1 mRNA. RAR␥ may directly cause the disassociation of SUZ12 from the Hoxa1 RARE and/or may indirectly cause SUZ12 disassociation through the transcription of the Hoxa1 gene.
